Thank you! Your request has been received.

A member of our team will reach out to you shortly,
Oops! Something went wrong while submitting the form.
+

Featured

Roche to Acquire 89bio for MASH Therapy Development

Roche has entered into a definitive merger agreement to acquire 89bio, Inc., a clinical-stage biopharmaceutical company, for up to $3.5 billion. The a...

September 18, 2025

September 2025

Roche to Acquire 89bio for MASH Therapy Development
Roche has entered into a definitive merger agreement to acquire 89bio, Inc., a clinical-stage biopharmaceutical company, for up to $3.5 billion. The a...
September 18, 2025

August 2025

Novartis Acquires Tourmaline Bio for $1.4 Billion, Expanding Cardiovascular Pipeline with Pacibekitug
Novartis announced its acquisition of Tourmaline Bio, a clinical-stage biopharmaceutical company, for approximately $1.4 billion. The acquisition cen...
September 9, 2025
Zydus and Synthon Partner for Ozanimod Capsules in the US Market
Zydus Lifesciences and Synthon BV have entered into an exclusive licensing and supply agreement for Ozanimod Capsules, a generic version of ZEPOSIA®, ...
September 5, 2025
Polpharma Biologics and MS Pharma Partner to Commercialize Biosimilars in MENA
Polpharma Biologics and MS Pharma have signed licensing agreements for the commercialization of three biosimilar candidates: vedolizumab (PB016), ocre...
September 2, 2025
Servier and IDEAYA Biosciences Partner to Develop Darovasertib for Uveal Melanoma
Servier and IDEAYA Biosciences announced an exclusive license agreement for darovasertib, a PKC inhibitor, for uveal melanoma treatment outside the US...
September 2, 2025
LakeShore Biopharma Receives Revised Acquisition Proposal
LakeShore Biopharma Co., Ltd. announced the receipt of a revised preliminary non-binding proposal from a consortium (Oceanpine Capital and Crystal Pea...
August 29, 2025
AbbVie Acquires Gilgamesh Pharmaceuticals' Bretisilocin for Major Depressive Disorder
AbbVie announced the acquisition of Gilgamesh Pharmaceuticals' bretisilocin, a novel Phase 2 psychedelic compound for treating moderate-to-severe majo...
August 26, 2025
AbbVie Acquires Capstan Therapeutics and its Novel CAR-T Therapy Candidate
AbbVie has completed its acquisition of Capstan Therapeutics, gaining access to CPTX2309, a first-in-class in vivo targeted lipid nanoparticle (tLNP) ...
August 20, 2025

July 2025

AleraCare and PURE Healthcare to Merge, Creating a Leading Ambulatory Infusion Platform
AleraCare, a provider of infusion and specialty pharmacy services, and PURE Healthcare, a medical group specializing in treating chronic conditions, a...
August 14, 2025
Melinta Therapeutics Acquired by CorMedix for $300 Million
Melinta Therapeutics, a commercial-stage biopharmaceutical company focused on acute and life-threatening illnesses, has been acquired by CorMedix Inc....
August 7, 2025
CorMedix to Acquire Melinta Therapeutics, Expanding its Specialty Pharmaceutical Portfolio
CorMedix Inc. announced a definitive agreement to acquire Melinta Therapeutics LLC for $300 million. This acquisition significantly expands CorMedix's...
August 7, 2025
Demetra Acquires OrthoFundamentals and Launches Global Spine Division
Demetra, a medical company specializing in bone cements and biomaterials, announced the acquisition of OrthoFundamentals, a provider of single-use sol...
August 4, 2025
Sanofi Acquires Rights to Arrowhead's Plozasiran for Hypertriglyceridemia in Greater China
Arrowhead Pharmaceuticals announced that its subsidiary, Visirna Therapeutics, has sold the rights to its investigational drug, plozasiran, for the tr...
August 4, 2025
Mallinckrodt and Endo Merger Creates Global Therapeutics Leader
Mallinckrodt plc and Endo, Inc. have completed their merger, forming a global leader in diversified therapeutics. The combined company boasts a broad ...
August 4, 2025
Hengrui Pharma and GSK Partner to Develop Up to 12 Innovative Medicines
Hengrui Pharma and GSK have entered into agreements to co-develop up to 12 innovative medicines across respiratory, immunology & inflammation, and onc...
July 28, 2025
Adaptimmune Sells Cell Therapies to US WorldMeds for $55 Million
Adaptimmune Therapeutics plc announced the sale of its TECELRA, lete-cel, afami-cel, and uza-cel cell therapies to US WorldMeds for $55 million in cas...
July 28, 2025
Gate Bioscience and Lilly Partner to Develop Molecular Gate Medicines
Gate Bioscience, a biotechnology company focused on molecular gate technology, announced a collaboration and license agreement with Eli Lilly and Comp...
July 25, 2025
Thermo Fisher and Sanofi Expand Partnership: Acquisition of Sterile Drug Manufacturing Site
Thermo Fisher Scientific announced an expansion of its strategic partnership with Sanofi. Thermo Fisher will acquire Sanofi's sterile manufacturing s...
July 17, 2025
Repare Therapeutics Outlicenses Lunresertib to Debiopharm
Repare Therapeutics has entered into an exclusive worldwide licensing agreement with Debiopharm for lunresertib, a first-in-class PKMYT1 inhibitor. D...
July 16, 2025

June 2025

Repare Therapeutics Outlicenses Lunresertib to Debiopharm
Repare Therapeutics has entered into an exclusive worldwide licensing agreement with Debiopharm for lunresertib, a first-in-class PKMYT1 inhibitor. D...
July 16, 2025
Cantargia Licenses CAN10 IL1RAP Immunology Program to Otsuka Pharmaceutical
Cantargia AB has announced an agreement with Otsuka Pharmaceutical for the acquisition of Cantargia's CAN10 program. Otsuka will acquire all assets r...
July 15, 2025
Sartorius Stedim Biotech and Sensible Biotechnologies Partner to Scale Up mRNA Manufacturing
Sartorius Stedim Biotech and Sensible Biotechnologies have signed a Memorandum of Understanding (MoU) to collaborate on the industrialization and scal...
July 10, 2025
Merck Acquires Verona Pharma for $10 Billion, Expanding COPD Treatment Portfolio
Merck has agreed to acquire Verona Pharma for approximately $10 billion. This acquisition brings Ohtuvayre (ensifentrine), a first-in-class COPD main...
July 9, 2025
Chugai and Gero Partner to Develop Novel Therapies for Age-Related Diseases
Chugai Pharmaceutical and Gero PTE. LTD. have entered a joint research and license agreement to develop novel antibody therapies for age-related disea...
July 8, 2025
Ligand Completes Merger with Channel Therapeutics, Launching ZELSUVMI™ for Molluscum Contagiosum
Ligand Pharmaceuticals announced the completion of its merger with Channel Therapeutics, forming Pelthos Therapeutics. Pelthos will launch ZELSUVMI™ ...
July 3, 2025
EnChannel Medical Acquires Acutus Medical's AcQMap™ Electrophysiology Assets
EnChannel Medical announced the acquisition of Acutus Medical's AcQMap™ High Resolution Imaging and Mapping platform assets. This acquisition strength...
July 2, 2025
Biofrontera Inc. Acquires US Rights to Ameluz® and RhodoLED®, Secures $11 Million Investment
Biofrontera Inc. announced the acquisition of all US assets related to Ameluz® and RhodoLED®, including the NDA and associated patents, from Biofronte...
July 1, 2025
23andMe Sold to TTAM Research Institute for $305 Million
23andMe, a genetics-led consumer healthcare company, has received court approval for the sale of substantially all of its assets to TTAM Research Inst...
June 30, 2025
Fujirebio Acquires Plasma Services Group, Strengthening its Biomaterials Supply
Fujirebio Diagnostics, a subsidiary of Fujirebio Holdings, Inc., has acquired Plasma Services Group, Inc., a provider of high-quality biological mater...
June 23, 2025
RyboDyn Joins Lilly Gateway Labs to Advance Next-Gen Immunotherapies
RyboDyn, a biotechnology company developing first-in-class immunotherapies targeting the 'dark proteome' (previously uncharacterized proteins), has be...
June 19, 2025
Pierre Fabre Laboratories Acquires Worldwide Rights for PFL-721 and PFL-241, Expanding its Oncology Portfolio
Pierre Fabre Laboratories announced the acquisition of worldwide rights for PFL-721 and PFL-241, mutant-specific EGFR inhibitors, from Antares Therape...
June 16, 2025

Latest Merger & Acquisitions

Roche to Acquire 89bio for MASH Therapy Development
September 18, 2025
Novartis Acquires Tourmaline Bio for $1.4 Billion, Expanding Cardiovascular Pipeline with Pacibekitug
September 9, 2025
Zydus and Synthon Partner for Ozanimod Capsules in the US Market
September 5, 2025
Polpharma Biologics and MS Pharma Partner to Commercialize Biosimilars in MENA
September 2, 2025
Servier and IDEAYA Biosciences Partner to Develop Darovasertib for Uveal Melanoma
September 2, 2025
LakeShore Biopharma Receives Revised Acquisition Proposal
August 29, 2025
AbbVie Acquires Gilgamesh Pharmaceuticals' Bretisilocin for Major Depressive Disorder
August 26, 2025
AbbVie Acquires Capstan Therapeutics and its Novel CAR-T Therapy Candidate
August 20, 2025
AleraCare and PURE Healthcare to Merge, Creating a Leading Ambulatory Infusion Platform
August 14, 2025
Melinta Therapeutics Acquired by CorMedix for $300 Million
August 7, 2025
CorMedix to Acquire Melinta Therapeutics, Expanding its Specialty Pharmaceutical Portfolio
August 7, 2025
Demetra Acquires OrthoFundamentals and Launches Global Spine Division
August 4, 2025
Sanofi Acquires Rights to Arrowhead's Plozasiran for Hypertriglyceridemia in Greater China
August 4, 2025
Mallinckrodt and Endo Merger Creates Global Therapeutics Leader
August 4, 2025
Hengrui Pharma and GSK Partner to Develop Up to 12 Innovative Medicines
July 28, 2025
Adaptimmune Sells Cell Therapies to US WorldMeds for $55 Million
July 28, 2025
Gate Bioscience and Lilly Partner to Develop Molecular Gate Medicines
July 25, 2025
Thermo Fisher and Sanofi Expand Partnership: Acquisition of Sterile Drug Manufacturing Site
July 17, 2025
Repare Therapeutics Outlicenses Lunresertib to Debiopharm
July 16, 2025
Cantargia Licenses CAN10 IL1RAP Immunology Program to Otsuka Pharmaceutical
July 15, 2025
Sartorius Stedim Biotech and Sensible Biotechnologies Partner to Scale Up mRNA Manufacturing
July 10, 2025
Merck Acquires Verona Pharma for $10 Billion, Expanding COPD Treatment Portfolio
July 9, 2025
Chugai and Gero Partner to Develop Novel Therapies for Age-Related Diseases
July 8, 2025
Ligand Completes Merger with Channel Therapeutics, Launching ZELSUVMI™ for Molluscum Contagiosum
July 3, 2025
EnChannel Medical Acquires Acutus Medical's AcQMap™ Electrophysiology Assets
July 2, 2025
Biofrontera Inc. Acquires US Rights to Ameluz® and RhodoLED®, Secures $11 Million Investment
July 1, 2025
23andMe Sold to TTAM Research Institute for $305 Million
June 30, 2025
Fujirebio Acquires Plasma Services Group, Strengthening its Biomaterials Supply
June 23, 2025
RyboDyn Joins Lilly Gateway Labs to Advance Next-Gen Immunotherapies
June 19, 2025
Pierre Fabre Laboratories Acquires Worldwide Rights for PFL-721 and PFL-241, Expanding its Oncology Portfolio
June 16, 2025
Medtronic Announces MiniMed as Name for Planned New Diabetes Company
June 13, 2025
BioNTech to Acquire CureVac in $1.25 Billion All-Stock Acquisition
June 12, 2025
Quell Therapeutics and AstraZeneca Advance CAR-Treg Cell Therapy for Inflammatory Bowel Disease
June 10, 2025
Sanofi Acquires Vigil Neuroscience to Expand Alzheimer's Disease Pipeline
May 22, 2025
CRISPR and Sirius Therapeutics Partner to Develop siRNA Therapies for Thromboembolic Disorders
May 20, 2025
Carlyle and SK Capital Complete Acquisition of bluebird bio
May 6, 2025
Repare Therapeutics Out-Licenses Discovery Platforms to DCx Biotherapeutics
May 2, 2025

Empowering Life Sciences with
Advanced AI Solutions.

Book A Demo
HomeKnolsightsContact UsPricing
One Research Court, Suite 450, Rockville, MD 20850
info@pienomial.com
+91 9876543210
© 2025 Pienomial. All rights reserved
AboutTerms of ServicePrivacy Policy
Home/KnloSights/Mregers And Acquisitions